CCL18
CCL18 is a small cytokine known as a chemokine that is also known as Pulmonary and Activation-Regulated Chemokine (PARC). It is expressed in the lung, lymph nodes, and peripheral blood leukocytes. CCL18 attracts immune cells, such as lymphocytes, monocytes, and dendritic cells, to sites of inflammation in the body.
Function[edit | edit source]
CCL18 is a member of the CC chemokine family, and is predominantly expressed in the lung, lymph nodes, and peripheral blood leukocytes. It has chemotactic activity for lymphocytes, monocytes, and dendritic cells. This chemokine is believed to play a role in pulmonary inflammation and fibrosis.
Clinical significance[edit | edit source]
CCL18 has been associated with various diseases, including pulmonary fibrosis, asthma, and cancer. It is often found at elevated levels in the blood plasma of patients with these conditions. In cancer, CCL18 has been shown to promote tumor growth and metastasis.
See also[edit | edit source]
References[edit | edit source]
CCL18 Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD